Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis
A Canadian clinical trial evaluating the utility of treatment optimization recommendations in relapsing-remitting multiple sclerosis has com…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Phase IIa Study of NT-KO-003 for Multiple Sclerosis [Phase 2]
A Phase IIa study evaluating NT-KO-003 for relapsing-remitting multiple sclerosis has completed, according to trial records.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)
A postmarketing surveillance study evaluated whether a variable titration regimen at the start of Rebif treatment improves patient complianc…
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients [Phase 4]
Phase 4 clinical trial from Tehran University of Medical Sciences evaluated vitamin A supplementation on immune parameters in relapsing-remi…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Autologous T Cell Vaccine (TCV) for Multiple Sclerosis [Phase 2]
Phase 2 trial of an autologous T cell vaccine (TCV) for relapsing-remitting multiple sclerosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis [Phase 2]
This entry documents the completion of a Phase 2 trial evaluating Rituximab in adults with relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS withdrawal · 2014-02-20Clinical Trial Update: Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis [Phase 3]
A Phase 3 clinical trial evaluating simvastatin as an add-on therapy to Copaxone (glatiramer acetate) for relapsing-remitting multiple scler…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: An Observational Study to Evaluate Quality of Life (QoL) and Influence of Cognitive Status on QoL in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) During 2 Years Treatment With Rebif New Formulation (RNF)
This completed observational study evaluated quality of life and the influence of cognitive status on QoL in relapsing-remitting multiple sc…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis [Phase 4]
Phase 4 trial evaluating de-escalation from natalizumab to interferon-beta-1b in relapsing-remitting multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate [Phase 4]
Phase 4 trial assessing the effect of steroids in Relapsing Remitting Multiple Sclerosis patients treated with glatiramer acetate; the study…
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis [Phase 2]
Phase 2 study evaluating the safety and efficacy of ONO-4641 in patients with relapsing-remitting multiple sclerosis; the trial has complete…
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) [Phase 3]
A Phase 3 safety and efficacy study of oral cladribine in relapsing-remitting multiple sclerosis has completed; results were posted in 2013.…
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: CLARITY Extension Study [Phase 3]
Phase 3 extension study update for relapsing-remitting multiple sclerosis; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif [Phase 4]
Phase 4 safety study in relapsing-remitting multiple sclerosis patients treated with Betaferon or Rebif; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients [Phase 3]
A Phase 3 trial comparing two glatiramer acetate formulations in relapsing-remitting multiple sclerosis completed with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: To Assess the Prevalence of Spasticity and the Impact on the Quality of Life in Multiple Sclerosis Patients
A completed clinical trial evaluating the prevalence of spasticity in relapsing-remitting multiple sclerosis and its impact on quality of li…
-
CLINICAL_TRIALS research · 2013-10-16Clinical Trial Update: Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)
A completed clinical trial evaluating sexual dysfunction, disability, and quality of life in patients with relapsing-remitting multiple scle…
-
CLINICAL_TRIALS research · 2013-09-23Clinical Trial Update: Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of NU100 in relapsing-remitting multiple sclerosis, with the current trial st…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: An Observational Study for the Assessment of Adherence, Effectiveness and Convenience of Rebif® Treatment in Relapsing Multiple Sclerosis Patients Using RebiSmart™.
An observational study evaluating adherence, effectiveness and convenience of Rebif treatment in relapsing-remitting multiple sclerosis pati…
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta [Phase 4]
A Phase 4 study completed to assess if restarting interferon-beta therapy after a washout period is beneficial for relapsing-remitting multi…
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS [Phase 4]
A Phase 4 trial evaluating Avonex (Interferon-beta-1a) with or without methylprednisolone for relapsing-remitting multiple sclerosis has com…
-
CLINICAL_TRIALS trial_result · 2013-09-06Clinical Trial Update: Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®
This post-authorization observational study reports on cognition and fatigue in relapsing-remitting multiple sclerosis patients treated with…
-
CLINICAL_TRIALS withdrawal · 2013-08-06Clinical Trial Update: Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects [Phase 4]
Phase 4 implementation study evaluating treatment optimization recommendations for relapsing-remitting multiple sclerosis has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Efficacy of Fish Oil in Multiple Sclerosis [Phase 4]
Phase 4 clinical trial results evaluate the efficacy of fish oil as an adjunct in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities
A completed clinical trial evaluating glatiramer acetate in relapsing-remitting multiple sclerosis, including participants with autoimmune c…